Cannabis Before Rehab Intake: How to Measure Your Use

When someone calls a residential program about cannabis, the intake conversation tends to slow down at the same point: how much, exactly? “Every day” is a start, but it does not tell a clinician whether that means a few draws on a vape pen at night or several dabs of concentrate spread across the day. This guide explains what an admissions team needs to know about cannabis use before a residential stay, how to measure that use in units a clinician can work with, and why the answer shapes the first week of treatment. If you would rather talk it through with a person, call Annandale at (855) 778-8668.

The Short Answer

Cannabis withdrawal is a recognised clinical problem, and planning for it starts with an accurate history. The National Institute on Drug Abuse reports that one study estimated 12.1% of people who use cannabis frequently experience withdrawal after stopping, and that there are currently no FDA-approved medications for cannabis use disorder or for medically assisted cannabis withdrawal. Because there is no single medication to lean on, a residential plan for cannabis use disorder rests on symptom support, behavioural therapy and a precise account of what the person used, in what form, how often and when they last used it (NIDA, Cannabis research topic page).

Why “How Much” Is Harder to Answer for Cannabis

Alcohol has the standard drink, which gives clinicians and patients a shared unit. Cannabis has nothing equivalent. The same person might use flower, pre-rolls, vape cartridges, concentrates such as wax, shatter or rosin, edibles, drinks and tinctures in the same week, and each is sold in a different unit: grams, cartridges, milligrams, servings.

Strength has also moved. The CDC reports that in research samples the average delta-9 THC concentration almost doubled, from 9% in 2008 to 17% in 2017, and notes that dispensary products often carry much higher concentrations than that (CDC, Understanding Your Risk for Cannabis Use Disorder). So “I have used the same amount for ten years” may describe the same habit but not the same exposure. That is why intake teams ask about the product as well as the frequency.

What an Intake Assessment Will Usually Ask

Exact wording varies by program, but most residential assessments cover the same ground. It helps to have answers ready before the screening call:

• Which forms you use (flower, cartridge, concentrate, edible, drink) and roughly what share of your use each one makes up.
• How much you use on a typical day, described in the unit the product is sold in, such as “half a gram of flower” or “most of a cartridge every two days”.
• The THC percentage or milligrams printed on the label of the products you use most.
• How many separate times you use in a day, and how soon after waking the first use happens.
• The date and time of your last use.
• How long you have used at the current level, and what happened during past attempts to cut down or stop.
• Every other substance you use, including alcohol, benzodiazepines, opioids, stimulants and nicotine, plus all prescribed medications.
• Any co-occurring condition you are being treated for, such as depression, anxiety, PTSD or ADHD, and who prescribes for it.

Why These Details Change the Plan

Product strength: Daily use of a high-THC concentrate generally points to a heavier physical adjustment than the same frequency of lower-strength flower, so clinicians weight potency alongside frequency.

Early-morning use: Using within the first hour of waking, or waking at night to use, can suggest the person is already managing withdrawal symptoms, which helps the team anticipate the first few days.

Sleep reliance: NIDA lists insomnia and strange or unsettling dreams among cannabis withdrawal symptoms, so someone who uses cannabis to fall asleep needs a sleep plan from the first night.

Other substances: Cannabis withdrawal is uncomfortable but not generally considered medically dangerous on its own; alcohol and benzodiazepine withdrawal can cause seizures and must be medically supervised, so co-use is often the factor that changes the level of care at admission.

Co-occurring conditions: Irritability, restlessness, anxiety and low mood appear both in cannabis withdrawal and in co-occurring conditions, so a dual diagnosis assessment separates the two over the first weeks rather than on day one.

If alcohol or benzodiazepines are part of the picture, do not stop them suddenly on your own before admission. Tell the admissions team, and ask whether a supervised medical detox in Los Angeles needs to come first.

Do This Today: A Seven-Day Use Log

The most useful thing you can bring to a screening call is a short written record. It takes a few minutes a day and replaces guesswork with something a clinician can read.

1. Start a note on your phone today. For each use, record the time, the product, the amount in the unit it is sold in, and the main reason (sleep, stress, boredom, habit, social).
2. Photograph the labels of the two or three products you use most, making sure the THC percentage or milligram figure is legible.
3. Add every other substance to the same log, including drinks, pills and nicotine, with times.
4. Write down your last use before the screening call and again on the day of admission.
5. Bring three questions to the call: How do you support sleep in the first week without cannabis? Which symptoms do you treat with medication, given there is no FDA-approved medication for cannabis withdrawal? How do you interpret urine drug screens that stay positive for THC after admission?

That last question matters more than most people expect. After heavy, long-term use, THC metabolites can remain detectable in urine well after the last use, so a positive screen in the first part of a stay does not by itself mean someone has used again. Asking how a program reads those results avoids a misunderstanding later.

What the First Weeks Usually Involve

NIDA notes that behavioural approaches, including cognitive behavioural therapy, motivational enhancement therapy and contingency management, can be effective for cannabis use disorder. In practice, early residential work tends to centre on a predictable daily routine, a protected sleep window, regular check-ins about withdrawal symptoms and individual therapy that looks at what cannabis was doing for the person, whether that was sleep, stress relief or filling time.

Annandale is a small, private six-bed residence in the Los Angeles and Pasadena area, so the early days are spent with a handful of other residents rather than a large unit. Irritability and poor sleep are expected in the first week and are discussed openly rather than treated as a setback. For a longer look at the condition itself, read our overview of cannabis use disorder in adults and residential care. Where depression, anxiety or trauma symptoms sit alongside substance use, care follows our dual diagnosis treatment approach, which treats both together.

When Residential Care Makes Sense

NIDA cites estimates that 22% to 30% of people who use cannabis have cannabis use disorder, which the DSM-5 defines as two or more of a set of listed problems occurring within a 12-month period. Most people with the condition are not treated in residential settings. A residential level of care is more often considered when outpatient attempts have not held, when alcohol or other drugs are also involved, when a co-occurring condition is complicating recovery from substance use, or when the home environment makes stopping very hard. The decision is made with a clinician after an assessment, not from a checklist online.

To find out whether a residential stay fits your situation, or to go through your seven-day log with someone, call (855) 778-8668.

If You Need Help Right Now

If you or someone you know is in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For a medical emergency, call 911. For free, confidential treatment referrals at any hour, SAMHSA’s National Helpline is available on 1-800-662-4357 (SAMHSA National Helpline).

Educational Disclaimer

This article is for general education and is not medical advice, diagnosis or treatment. Withdrawal experiences vary, and alcohol or benzodiazepine withdrawal can be dangerous without medical supervision. Talk with a qualified clinician about your own situation before changing any substance or medication use. Annandale Behavioral Health provides residential treatment for substance use disorders, including co-occurring mental health conditions in people who are also being treated for substance use.